zanubrutinib,ibrutinib
beigene,Janssen,Abbvie
['ibru', 'zanubrutinib', 'cll']
#eha2023 #cll in pooled head-to-head studies, rates of death due to cardiac events were lower with zanubrutinib than ibrutinib (0.2 vs 1.7%) p631 
Este es el Twitter del Grupo Español de Leucemia Linfocítica Crónica